Anti-apoptotic molecule BCL2 is a therapeutic target in steroid-refractory graft-versus-host disease. Strobl J, Pandey RV, Kausgruber T, Kleissl L, et al. J Invest Dermatol 2020 Apr 2. pii: S0022-202X(20)31252.

Read + Share

Amedeo Smart

Independent Medical Education

Strobl J, Pandey RV, Kausgruber T, Kleissl L, et al. Anti-apoptotic molecule BCL2 is a therapeutic target in steroid-refractory graft-versus-host disease. J Invest Dermatol 2020 Apr 2. pii: S0022-202X(20)31252.
PMID: 32247860